THE Therapeutic Goods Administration (TGA) has now amended its guidelines on advertising of cosmetic injectables.
In its latest update, the TGA no longer permits direct or indirect references to prescription medicine in advertising related to cosmetic health services.
The regulatory authority stated that the previous references were only allowed in the context of promoting the service and when using generic non-product specific terms such as 'wrinkle reducing injections'.
Express references to products or ingredients themselves, such as 'Botox' or 'botulinum toxin', were anyway not permitted.
The TGA commented that it considered this a pragmatic approach, which would allow cosmetic clinics who offered these services to differentiate themselves from those that did not.
Recently, the TGA has observed that health services in related industry areas are advertising the availability of prescription medicines, usually by referring to a class of goods for example 'weight loss injections', 'medicinal cannabis' or 'nicotine vaping products'.
The TGA has interpreted that promoting a health service in this way is also considered an advertisement for a therapeutic good that refers to prescription medicines, which is unlawful.
To learn more CLICK HERE. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 24
